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or proteinuria score and number of casts, the predictive 
probability increased to 90.6% (AUC 0.97). Follow-up of the 
included patients showed no benefit of dRBC to identify pa-
tients at risk for glomerular disease.  Conclusions: The diag-
nostic value of routinely collected urinary dRBC to diagnose 
glomerular disease in patients presenting with hematuria is 
modest. However, including dRBC with other variables, such 
as age and erythrocyte score on dipstick testing may in-
crease the sensitivity, but needs to be confirmed in another, 
preferably larger, population. 
 
Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Hematuria is a common problem in clinical practice, 
with a reported prevalence ranging from 0.2 to 16.1%, 
depending on population screened  [1–2] . Transient he-
maturia can be caused by vigorous exercise, sexual in-
tercourse, mild trauma or menstrual contamination. 
Persistent hematuria can generally be divided into he-
maturia of glomerular and nonglomerular sources. 
Common causes of glomerular hematuria are glomeru-
lonephritis, IgA nephropathy, thin membrane disease 
and Alport’s disease  [3] . Hematuria of nonglomerular 
origin usually results from urological abnormalities, 
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 Abstract 
 Background: In clinical practice, discriminating between 
glomerular and nonglomerular causes of hematuria is often 
difficult. Dysmorphic red blood cells (dRBC) in the urinary 
sediment are claimed to be effective, but the cutoff points 
in the literature vary. This follow-up study aimed to deter-
mine the diagnostic value of dRBC.  Methods: We investigat-
ed 134 hematuria patients in the departments of nephrolo-
gy and urology. To diagnose the origin of hematuria, uro-
logical and/or nephrological examination was performed 
and the %dRBC identified by microscopy. Follow-up was 
performed after 3.5 years.  Results: The cause of hematuria 
was proven in 68 patients (35% glomerular; 65% nonglomer-
ular). Patients with glomerular disease had significantly 
more albuminuria and dRBC than patients with nonglomer-
ular disease, but the %dRBC ranged from 1 to 50% and no 
optimal cutoff could be identified. Logistic regression analy-
sis showed that %dRBC had a predicted probability to diag-
nose glomerular disease of 77.9% (area under the curve, 
AUC, 0.85). When %dRBC was combined with other risk fac-
tors such as serum creatinine, sex, age, dipstick erythrocyte 
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such as urinary tract infections, urological malignancy 
or urolithiasis.
 As it is important to exclude the presence of a urolog-
ical malignancy as the source of bleeding, patients pre-
senting with hematuria primarily undergo urological 
analysis  [4–5] . According to the guidelines of the Ameri-
can Urological Association, the urological evaluation of 
hematuria should include radiological imaging of the up-
per urinary tract followed by cystoscopic evaluation of 
the urinary bladder or additional examinations, depend-
ing on additional risk factors for urological disease  [5] . 
Patients with persistent hematuria in whom the urologi-
cal analysis is negative and having additional symptoms 
such as hypertension, proteinuria or renal impairment, 
should be referred to the nephrologist to be evaluated for 
glomerular disease.
 Urinalysis is still considered an important diagnostic 
tool for nephrologists. Although dipstick testing is easy 
to perform in general practice, the morphology of uri-
nary red blood cells (RBC) has been advocated as a fine 
diagnostic tool to differentiate between glomerular and 
nonglomerular causes of hematuria  [6–8] . In glomerular 
hematuria, the variation in size and shape of the urinary 
RBC is increased, and such RBC are generally called
dysmorphic RBC (dRBC). The exact pathophysiological 
mechanism of the formation of dRBC is unknown. Nev-
ertheless, it is hypothesized, based on in vitro evidence, 
that dRBC are RBC which leaked through the diseased 
glomerulus and were damaged by mechanical and os-
motic influences during their passage through the tubu-
lar system of the kidney, especially the collecting duct 
 [9–13] . In contrast, in nonglomerular hematuria urinary 
RBC have a more uniform morphology and are therefore 
called isomorphic RBC.
 In theory, a low percentage of dRBC (%dRBC) ex-
cludes a glomerular cause of hematuria and it is therefore 
not indicated to refer these patients to a nephrologist, 
whereas a higher %dRBC may demand further examina-
tion for glomerular disease. However, in the literature 
there is widespread controversy regarding the diagnostic 
value of urinary dRBC to identify the hematuria as glo-
merular in origin, because the criteria for dysmorphism 
of the urinary erythrocytes are vague and not standard-
ized. Various dRBC have been identified based on their 
morphology such as acanthocytes or G1 cells  [14–17] . 
Moreover, reported cutoff points of the %dRBC range 
from 10 to 90%, depending on screened population and 
study design  [6, 18–20] . 
 The present study was undertaken to determine the 
diagnostic value of urinary dRBC in 134 patients present-
ing with hematuria in both urological and nephrological 
outpatient departments. After inclusion, the percentage of 
urinary dRBC was determined and was correlated with 
the clinical diagnosis of the source of the hematuria.
 Patients and Methods 
 Study Protocol 
 Clinicians (both nephrologists and urologists) included pa-
tients referred for hematuria to the outpatient departments of ne-
phrology and urology in the Erasmus Medical Center (2002–
2004). Hematuria was defined as 1 + ( 6 20 RBC/  l) after dipstick. 
During the study period, the treating physicians remained re-
sponsible for the care of the patients included in this study. Treat-
ing physicians were not aware of the results of urinalysis and the 
investigators did not intervene at any point. After a follow-up of 
3.8 (0–6.7) years, it was investigated whether the included hema-
turia patients had developed glomerular disease. Follow-up infor-
mation was retrieved from the hospital electronic information 
system. 
 Study Groups 
 Per patient, the final diagnosis was collected by reviewing 
clinical charts, the electronic hospital information system and 
discharge letters. The level of certainty that the definitive diagno-
sis was indeed the cause of hematuria was scored in five diagnos-
tic groups (numbered –2 to +2;  table 1 ). Patients in whom a glo-
merular source of hematuria was proven by renal biopsy (e.g. glo-
merulonephritis or IgA nephropathy) were classified as +2, 
whereas those in whom urological examination identified a de-
finitive urological source of bleeding (e.g. urinary tract infection, 
malignancy of the urinary tract or urolithiasis) were classified as 
–2. Cases in which the cause of hematuria was totally unknown 
were coded as 0. In diagnostic groups +1 and –1, there were find-
ings indicating either a glomerular or a urological source, but no 
final diagnosis for the hematuria was made. In our analyses of the 
predictive value of urinary dRBC, only patients with a proven 
cause (i.e. diagnostic groups –2 and +2) were included and the 
percentage of urinary dRBC correlated with clinical findings and 
definitive diagnosis.
 Analytical Methods 
 Fresh urine samples were analyzed within 2 h after voiding or 
fixated with CellFIX TM (Becton Dickinson, San Jose, Calif., USA). 
Firstly, before microscopic examination of the urine sediment, 
the urine specimens were routinely examined with an automated 
semiquantitative urinalysis using Combur 10 Test M strips on a 
Miditron  M (Roche Diagnostics, Mannheim, Germany). Hema-
turia was scored in +, ++ and +++ corresponding to 3–20, 20–100 
and  1 100 erythrocytes/  l, respectively. Using the same test sys-
tem, albuminuria was also measured semiquantitatively (+ = 
200–500 mg/l; ++ = 500–1,000 mg/l; +++ =  1 1,000 mg/l)  [21] . 
Urinary pH was measured on a semiquantitative scale with incre-
ments of 0.5. To estimate renal function of each patient, serum 
creatinine was measured.
 Next, urine samples (6–12 ml, depending on concentration of 
erythrocytes) were centrifuged in a Kova tube (Instruchemie, 
Delfzijl, The Netherlands) at 1,600 rpm for 5 min. Supernatant was 
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discarded, and a drop of sediment suspension was placed on a slide 
with a covering glass. The presence of erythrocyte casts was exam-
ined using a bright-field microscope (Olympus, PAES, The Neth-
erlands), while the presence of dRBC was examined using phase-
contrast microscopy under high-power magnification ( ! 400). In 
each case, 100 erythrocytes were counted to determine the percent-
age of dysmorphic erythrocytes. Dysmorphic erythrocytes were 
defined using the criteria as reported previously  [6, 22–23] . In brief, 
dysmorphic erythrocytes exhibited irregular membranes or small 
surface blebs and showed an annular or vesicular structure. Hema-
turia of a glomerular source shows a polymorphic aspect and 
erythrocyte casts can be present. In this study, we did not discrim-
inate between the different types of dysmorphic erythrocytes, al-
though the presence of erythrocyte casts was scored separately.
 Examination was carried out by two well-trained technicians. 
If trained technicians were not present at the time the urine sam-
ple was delivered to the laboratory, a CellFIX fixation method was 
used as described by Huussen et al.  [24] . The technicians were 
blinded to their colleagues’ results and the patients’ clinical infor-
mation. 
 Statistical Analysis 
 The level of albuminuria and the %dRBC were compared us-
ing the Fisher exact test. The mean %dRBC in the five diagnostic 
groups were compared using a one-way ANOVA. Serum creati-
nine levels in these groups were compared using Friedman’s 
ANOVA by ranks. If either yielded a significant F, multiple 
posthoc comparisons were performed using the Student-New-
man-Keuls test. Interobserver variation of counted %dRBC was 
assessed by means of a Bland-Altman plot and the calculation of 
the Wilcoxon signed ranks test. Sensitivity was calculated as the 
proportion of all patients with the disease (true positives + false 
negatives) who indeed have a positive test result (true positives), 
as defined previously  [25] . Specificity was calculated as propor-
tion of all patients without the disease and a negative test result 
(true negatives) of all those without the disease (true negatives + 
false positives). Binary logistic regression analysis was performed 
to make a prediction model for the variables: (1) dipstick erythro-
cytes score, (2) %dRBC; (3) dipstick proteinuria score; (4) sex; (5) 
age; (6) number of erythrocyte casts, and (7) serum creatinine. 
ROC curves of the predicted probabilities were made. Data were 
analyzed using SPSS (version 15.0; Chicago, Ill., USA). Data are 
expressed as mean  8 standard deviation, or as median (range), 
depending on the distribution of the data. Area under the curve 
(AUC) is shown with 95% confidence interval. Statistical signifi-
cance was defined as p  ! 0.05.
 Results 
 Patients 
 In this study, 134 patients presenting with hematuria 
in the outpatient departments of nephrology and urology 
were included. In total, 93 adults and 41 children ( ! 18 
years) were included, including 68 females (50.7%). The 
median age of this study population was 43 (1–86) years. 
The median creatinine concentration in serum was 71.5 
  M (11–454).
 Semiquantitative Urinalysis 
 Hematuria in the included patients had the following 
distribution: + in 24 (17.9%), ++ in 19 (14.2%) and +++ in 
91 (67.9%;  table 2 ). Albuminuria was present in 26.9% 
(36/134) of all cases, and higher levels of albuminuria were 
significantly associated with higher levels of hematuria
(p  ! 0.05). Interestingly, in the group with proven uro-
Table 1. Diagnostic groups
Diagnostic
group
Diagnostic cause of
hematuria 
Final diagnoses 
–2 Proven urological (44) Urinary tract infection (21)
Obstructive uropathy (10), including:
urolithiasis (5)
benign prostate hypertrophy (1)
malignancy of the urinary tract (4)
Other (10): e.g. trauma, (congenital) anatomic abnormalities,
anticoagulant drugs
Non-glomerular renal disease (3): e.g. fibrosis
–1 Possible urological (14)
0 Uncertain (35)
+1 Possible glomerular (16)
+2 Proven glomerular (24) Glomerulonephritis (18): primary/secondary
IgA nephropathy (6)
Figures in parentheses indicate number of cases.
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logical disease, i.e. diagnostic group –2, there were still 6 
patients who had 3+ albuminuria scored on the test strip. 
However, the mean counted percentages of urinary dRBC 
in these patients ranged from 1 to 18. The median urinary 
pH in the general study population was 6.0 (5.0–8.0).
 Microscopic Analysis of the Urine Sediment 
 The %dRBC detected in the urine samples ranged 
from 1 to 71%.  Figure 1 shows the distribution of the per-
centages of urinary dRBC of all 134 hematuria patients 
included in this study population. There was no signifi-
cant difference in %dRBC counted by the two techni-
cians.  Figure 2 shows a Bland-Altman plot of the mean 
differences of the dRBC counts by observer 1 and 2. The 
%dRBC was significantly higher in the ++ than in the + 
and +++ hematuria groups (p  ! 0.05;  table 2 ). Erythro-
cyte casts were found in 6 of the 134 samples.
 Diagnostic Performance 
 Dysmorphic RBC 
 In total, we found 68 (51%) patients with a proven cause 
of hematuria, either urological or glomerular.  Table 1 
shows the definitive diagnoses of the patients with a prov-
en origin of the hematuria after urological and/or nephro-
logical examination. In 66% (27/41) of the pediatric pa-
tients, a proven cause of hematuria was found: 48% (13/27) 
nonglomerular and 52% (14/27) glomerular. In adult pa-
tients, 79% (33/42) had a urological and 21% (9/42) had 
glomerular pathology as the cause of hema turia.
 The percentage of urinary dRBC differed significantly 
between the five diagnostic groups and was highest in the 
group with proven glomerular disease (p  ! 0.05;  table 3 ). 
Table 2. Results of urine semiquantitative test strip and micro-
scopic analysis of 134 hematuria patients
Hematuria
overall + ++ +++
(n = 134) (n = 24) (n = 19) (n = 91)
Albuminuria
+
++
+++
0
0
1
2
2
1
10
9
11
Total 36 1 5 30a
%dRBC 15 (10) 26 (12)a, b 17 (13)
Erythrocyte casts 6 1 2 3
a p < 0.05 vs. + ; b p < 0.05 vs. +++. Values for %dRBC are ex-
pressed as mean (SD).
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 Fig. 1. Frequency distribution of microscopically counted %dRBC 
in 134 hematuria patients. Percentages are shown as medians of 
two measurements. 
 Fig. 2. Interobserver variability of counted %dRBC (Bland-Alt-
man plot). The mean differences between the counted percent-
ages of urinary dRBC by 2 technicians (count 1 and count 2) were 
plotted. 
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Albuminuria was also significantly higher in the group 
in which the hematuria resulted from a glomerular 
 disease (p  ! 0.05). Serum creatinine concentrations
were not significantly different in the various diagnostic 
groups. Patients with proven glomerular hematuria were 
significantly younger than patients in the other diagnos-
tic groups (p  ! 0.05).
 Cutoff Value 
 As various cutoff points have been reported in the lit-
erature, we were interested what the effect was of differ-
ent cutoff values on the sensitivity and specificity of uri-
nary dRBC for glomerular disease. In  table 4 , the results 
of these calculations are shown. Using a cutoff point of 
40% dRBC showed that none of the patients with a 
Table 3. Characteristics and results of urinalysis of diagnostic groups
Diagnostic group  –2
Proven
urological
 –1
Possible
urological
0
Uncertain
1
Possible
glomerular
2
Proven
glomerular
Patients 44 15 35 16 24
Female sex 20 (45.5%) 11 (73.3%) 19 (54.3%) 5 (31.3%) 9 (37.5%)
Age 41.9 8 24.4 45.9 8 27.8 48.5 8 17.4 31.6 8 20.1c 21.8 8 15.4a–c
Children 13 (28.3%) 4 (28.6%) 3 (8.6%) 7 (43.8%) 14 (60.9%)
Serum creatinine, M 79 (12–454) 59 (32–273) 74 (27–297) 71 (11–110) 64 (29–211)
Semiquantitative urinalysis
Albuminuria
1+
2+
3+
Total
4
5
6
15/46
1
0
1
2/14
0
1
0
1/35
0
2
1
3/16
7
3
5
15/23a–d
Erythrocyturia
1+
2+
3+
Total
9
7
30
46
5
2
7
14
9
5
21
35
0
4
12
16
1
1
21
23
pH 6.0 (5.0–8.0) 6.0 (5.0–8.0) 6.0 (5.0–8.0) 6.0 (5.0–7.0) 6.0 (5.0–8.0)
 Microscopic analysis 
%dRBC 1287 21813 18815 22813a 25813a, c
Erythrocyte casts 0 1 2 0 3
a p < 0.05 vs. group –2; b p < 0.05 vs. group –1; c p < 0.05 vs. group 0; d p < 0.05 vs. group 1. Values for serum creatinine and pH are 
expressed as median (range), and values for %dRBC as mean 8 SD.
Table 4. Sensitivity and specificity of %dRBC for diagnosing glomerular disease at various cutoff points in 68 patients with proven 
disease
Cutoff points Positive test for proven
urological disease, n 
Positive test for proven
glomerular disease, n 
Sensitivity of %dRBC
for glomerular disease, % 
Specificity of %dRBC
for glomerular disease, %
0% 44 24 100 (24/24) 0 (44/44)
10% 24 23 96 (23/24) 45 (20/44)
20% 4 13 54 (13/24) 91 (40/44)
30% 1 6 25 (6/24) 98 (43/44)
40% 0 5 21 (5/24) 100 (44/44)
50% 0 2 8 (2/24) 100 (44/44)
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 proven urological cause of hematuria had an increased
%dRBC in their urine ( fig. 3 ), while only 5 of the 23 pa-
tients with a histological proven glomerular cause of he-
maturia had an elevated percentage ( 1 40%) of urinary 
dRBC. Thus, at a 40% cutoff point the sensitivity of uri-
nary dRBC for excluding glomerular disease in patients 
with urological diseases was 100% (46/46 dRBC  ! 40%), 
while still 78% of the patients with a glomerular cause of 
hematuria had less than 40% dRBC. None of the patients 
with proven urological disease showed dRBC above the 
cutoff of 40%. 
 Binary logistic regression analysis of all patients with 
proven causes of hematuria showed that the predicted 
probability of %dRBC for glomerular disease was 77.9%. 
The ROC curve of the predicted probability of %dRBC is 
shown in  figure 4 a with an estimated AUC of 0.84 (0.76–
0.95). Addition of proteinuria to %dRBC hardly increased 
the predicted probability to 79.4%, AUC 0.86 (0.77–0.95; 
 fig. 4 a). The predicted probability for glomerular disease 
improved to 90.6%, AUC 0.97 (0.94–1.00) when the fol-
lowing variables were added to the prediction model: (1) 
dipstick erythrocyte score, (2) %dRBC, (3) dipstick pro-
teinuria score, (4) sex, (5) age, (6) erythrocyte casts and 
(7) serum creatinine ( fig. 4 b). The regression formula of 
this full model was: (glomerular disease) = –14.9 –3.93   
(erythrocyte score) +0.48   (%dRBC) +0.35   (proteinuria 
score) –2.29   (sex) –0.10   (age) +21.54   (erythrocyte 
casts) –0.004   (serum creatinine).
 Based on our data, only %dRBC, dipstick erythrocyte 
score and age significantly contributed to the prediction 
model. The regression formula of this reduced model 
was: (glomerular disease) = –8.7 +0.25   (%dRBC) +2.13 
  (erythrocyte score) –0.058   (age).  Figure 4 b shows the 
ROC curve of the predicted probabilities of this reduced 
model. The predictive probability of this model was
85.3% with an AUC of 0.95 (0.89–1.00).
 Erythrocyte Casts 
 In our study, erythrocyte casts were seen in 6 out of 
134 cases ( table 2 ,  3 ). Five of those patients had ++ or 
more erythrocytes on the test strip. In 3 out of the 6, the 
origin of hematuria (all glomerular) was found. One pa-
tient had IgA glomerulopathy and 2 patients suffered 
from glomerulonephritis. The percentages of urinary 
dRBC were 5, 21 and 34, respectively.
 Follow-Up 
 To determine whether dysmorphic erythrocytes had a 
predictive value for the development of glomerular dis-
ease in the long-term, we reevaluated several years after 
inclusion whether the hematuria patients developed glo-
merular disease. The median follow-up time was approx-
imately 3.8 years, with a maximum of 6.7 years. One year 
after inclusion, 29 patients were lost to follow-up, which 
was likely due to discharge or referral of patients to other 
hospitals. The follow-up of the rest of the patients was 1–4 
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 Fig. 3. %dRBC per diagnostic group de-
fined on certainty of the cause of hematu-
ria. At a percentage of 40% dRBC, a hori-
zontal line is drawn showing the diagnos-
tic value of dRBC at this cutoff value for 
each diagnostic group: all patients with 
proven urological pathology had less than 
40% dRBC, whereas 5 patients with prov-
en glomerular pathology had more than 
40%. In 3 diagnostic groups (possible uro-
logical, uncertain and possible glomeru-
lar), no final cause of hematuria could be 
made. 
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years (46 patients), while 59 patients had been followed 
for at least 4 years. It can be hypothesized that patients 
with a high percentage of urinary dRBC might be at risk 
to have or develop glomerular disease. From the 7 pa-
tients with more than 40% dRBC and no previously di-
agnosed glomerular disease, one patient developed IgA 
nephropathy after a follow-up of 2.0 years. In contrast, 
there were 2 patients with a proven urological cause who 
both developed IgA nephropathy, while the %dRBC was 
only 10 and 11 in their urine sediments.
 Discussion 
 This study, performed in 134 patients presenting with 
hematuria in both urological and nephrological outpa-
tient departments, shows that the measurement of uri-
nary dRBC has a moderate diagnostic value to identify 
glomerular disease. Therefore, it may be useful in the 
urological department to identify patients with glomeru-
lar diseases who may benefit from referral to a nephrolo-
gist. 
 In only 51% of the patients in our study could a defi-
nite diagnosis explaining the hematuria be made after a 
full urological and/or histopathological evaluation: 18% 
with glomerular pathology versus 34% with urological 
pathology. Although this percentage appears low, previ-
ous studies reported similar percentages of identified 
causes of hematuria (ranging from 32 to 90% even after 
full examination)  [4, 5, 26] . We failed to determine opti-
mal diagnostic cutoff values, which was due to the wide 
frequency distribution of urinary dRBC in these pa-
tients.
 The Value of dRBC in Urological Disease 
 In our study, 34% of all patients had proven urological 
pathology. We found that these patients were significant-
ly older than the patients in the other diagnostic groups. 
This most likely resulted from the fact that urinary tract 
infections, malignancies of the urinary tract, prostate hy-
pertrophy and stones are more frequent in elderly  [27, 28] . 
All patients with a urological cause of hematuria had less 
than the arbitrary chosen level of 40% dRBC in their 
urine. This would suggest that identifying  6 40% dRBC 
in the urinary sediment excludes urological pathology. 
Using this argument, it has been suggested that all pa-
tients with more than 40% urinary dRBC should be re-
ferred to a nephrologist as they have a low risk of uro-
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 Fig. 4. ROC curves of predicted probabilities for glomerular dis-
ease in patients with proven disease.  a ROC curves of the predict-
ed probability of %dRBC only, proteinuria only and a combina-
tion of %dRBC and proteinuria to identify glomerular disease.
 b ROC curves of the predicted probability of %dRBC only, all risk 
factors (full prediction model) and the reduced prediction model. 
The full prediction model consisted of %dRBC, erythrocyte score 
on dipstick, proteinuria score on dipstick, sex, age, serum creati-
nine and number of erythrocyte casts. The reduced prediction 
model consisted of %dRBC, erythrocyte score on dipstick and 
age. 
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logical disease and may be spared a full urological work-
up  [26] . However, patients with a high %dRBC due to 
subclinical glomerular abnormality (such as thin mem-
brane disease) may also develop a urological malignancy. 
Indeed, the question remains how such high %dRBC can 
occur in patients with a urological source of hematuria. 
There is no clear pathophysiological explanation for this, 
as dRBC are supposed to be formed in the tubular system 
of the kidney due to mechanical and osmotic changes and 
not in the lower urinary tract  [29] . A possible explanation 
for the relatively high %dRBC in these patients with an 
established urological cause could be the coexistence of 
(subclinical) glomerular disease pathology, such as thin-
membrane disease. Some reports estimate the frequency 
of this disorder to be as high as 1–10% in the general pop-
ulation  [30] . However, for obvious reasons, renal biopsy 
was not performed in these patients. Six patients with 
proven urological disease and low urinary dRBC ( ! 40%) 
had a significant amount of albuminuria on the test strip. 
These patients would not have been identified by the use 
of only urinary dRBC, but should nevertheless be re-
ferred to a nephrologist for the investigation of coexisting 
renal disease. 
 Follow-up showed that 2 patients with proven urolog-
ical disease developed glomerular disease, although the 
%dRBC in their urine sediment was only 10 and 11%, re-
spectively. This suggests that the determination of uri-
nary dRBC is not useful to detect glomerular disease in 
the urological department, but may be useful to exclude 
glomerular disease in patients with urological diseases.
 The Value of dRBC in Glomerular Disease 
 In total, 18% of the patients enrolled in our study had 
biopsy-proven glomerular disease. When investigating 
the diagnostic value of urinary dRBC for glomerular dis-
ease, we found that the percentage of urinary dRBC was 
significantly higher in patients with proven glomerular 
disease than in patients with urological pathology. How-
ever, a low %dRBC did not rule out glomerular pathology 
as the %dRBC ranged from 1 to 50%. Albuminuria is an 
important indicator of glomerular damage and was sig-
nificantly more frequent in patients with proven glomer-
ular hematuria. Two of these patients had no albumin-
uria at all, leaving dRBC as the only indicator of a glo-
merular abnormality. Conversely, 8 patients with proven 
glomerular disease had marked albuminuria but less 
than 40% urinary dRBC. These patients would not have 
been identified by the use of urinary dRBC alone, and 
this finding challenges the validity of dRBC as a diagnos-
tic tool for glomerular disease. Serum creatinine, as an 
estimate of glomerular filtration rate, could also be of val-
ue for diagnosing glomerular disease. In our study, how-
ever, there was no significant difference in serum creati-
nine between the diagnostic groups. In the 5 patients 
with proven glomerular disease and dRBC  1 40%, the 
median serum creatinine concentration was 61 (range 
40–71)   M and did not add to the diagnosis. Another in-
dication that glomerular pathology is the cause of hema-
turia is the presence of urinary erythrocyte casts which 
is virtually pathognomonic of glomerular bleeding. Un-
fortunately, they are a relatively insensitive marker and 
are frequently not present in urine of patients with glo-
merular pathology  [18, 19] . In our study, erythrocyte 
casts were observed in only 6 urine specimens, which 
were in 3 out of the 6 cases derived from patients with 
proven glomerular disease.
 Furthermore, it can be hypothesized that using a com-
bination of variables/risk factors such as %dRBC, eryth-
rocyte score on dipstick, proteinuria score on dipstick, 
sex, age, serum creatinine and number of erythrocyte 
casts, can increase the sensitivity for glomerular disease. 
In our hands, especially %dRBC, age and erythrocyte 
score on dipstick showed a significant contribution to 
predict glomerular disease. Although these findings 
should first be confirmed in another, preferably larger, 
study population, we can speculate that the composition 
of a scoring system based on these risk factors may im-
prove the identification of patients with glomerular dis-
ease. This can be of special interest in the department of 
urology to identify patients who need referral to a ne-
phrologist. 
 Study Limitations 
 In our study, we did not routinely acidify hematuria 
patients before obtaining urine samples, and our analysis 
showed that the median pH of the urinary specimens was 
6.0. This may have affected our results, as both the gen-
eration of dRBC and the formation of erythrocyte casts 
is enhanced by acidic urine  [9, 29] . Urinary osmolality 
has also been reported to be important for the formation 
of dRBC and erythrocyte casts  [9] . However, in our study, 
urine osmolality was not measured and no specific effort 
was made to ensure that concentrated urine samples were 
obtained, although all samples were collected in the 
morning. All urine specimens were analyzed within 2 h 
after voiding or fixated with CellFIX. Moreover, we found 
that fixation did not affect the percentages of dRBC in the 
urine (data not shown), which is in line with the previous 
literature  [24] . Possibly, the %dRBC in patients with renal 
disease can be increased, thus increasing the sensitivity, 
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by a more rigorous study protocol, controlling both pH 
and osmolality in the urine samples. However, in none of 
the previously reported studies was such a protocol ap-
plied. Moreover, preconditioning of the patient would se-
verely hamper the application of this test in clinical prac-
tice.
 To standardize measurements and to reduce the work-
load of conventional microscopic examination, automat-
ed systems using computer-assisted light microscopy  [31, 
32] , immunocytochemical staining, flow cytometric 
analysis of erythrocytes  [33] or measurement of size or 
mean corpuscular volume of erythrocytes  [34] have been 
used in the laboratories. These methods, however, are still 
not qualified to detect and quantify urinary dRBC. The 
sensitivity and specificity of these methods to diagnose 
pathology are still under investigation, and manual mi-
croscopic examination is still required to identify some 
cell types  [35] . The present study evaluated whether there 
is still reason to perform manual microscopic examina-
tion of urinary specimens in clinical practice.
 An unanswered, yet important, question is: should all 
patients with isolated hematuria and high percentages of 
urinary dRBC be referred to a nephrologist? Follow-up of 
patients with more than 40% dRBC and no previously 
proven glomerular disease showed that only one of the 7 
developed glomerular disease during this period, sug-
gesting that a high dysmorphism of urinary RBC does 
not predict glomerular disease in the short-term.
 Furthermore, the definitive diagnosis of glomerular 
disease can only be made by renal biopsy. This is often 
not indicated, as the likelihood of finding a treatable dis-
ease in isolated glomerular hematuria is very low and 
these patients appear to have a low risk of progressive re-
nal disease  [36] . In these patients, a conservative policy is 
justified and regular monitoring of these patients for the 
development of hypertension, renal insufficiency and al-
buminuria appears sufficient.
 In conclusion, this follow-up study in patients present-
ing with hematuria shows that the diagnostic value of 
routinely collected urinary dRBC to diagnose glomerular 
disease is modest, as the presence of a low %dRBC failed 
to exclude glomerular disease. Although there is an ur-
gent need for both urologists and nephrologists to dis-
criminate between hematuria of glomerular and nonglo-
merular origin, we feel that currently the manual deter-
mination of urinary dRBC is not recommended in 
clinical practice. Making a scoring system based on a 
combination of several risk factors, especially %dRBC, 
age and erythrocyturia, may increase the probability to 
identify glomerular disease. This needs to be further in-
vestigated in another, preferably larger, population.
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